Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2016/02/23
-
Indian UGC (journal)
-
Refrences43
-
Citations14
-
Ricardo Lamy Department of Ophthalmology University of California ‐ San Francisco San Francisco California USA
-
Elliot Chan Department of Ophthalmology University of California ‐ San Francisco San Francisco California USA
-
Samuel D Good Department of Ophthalmology University of California ‐ San Francisco San Francisco California USA
-
Vicky Cevallos Francis I. Proctor Foundation University of California ‐ San Francisco San Francisco California USA
-
Travis C Porco Francis I. Proctor Foundation University of California ‐ San Francisco San Francisco California USA
-
Jay M Stewart Department of Ophthalmology University of California ‐ San Francisco San Francisco California USA
Abstract
Cite
Lamy, Ricardo, et al. “Riboflavin and Ultraviolet A As Adjuvant Treatment Against Acanthamoeba Cysts”. Clinical &Amp; Experimental Ophthalmology, vol. 44, no. 3, 2016, pp. 181-7, https://doi.org/10.1111/ceo.12644.
Lamy, R., Chan, E., Good, S. D., Cevallos, V., Porco, T. C., & Stewart, J. M. (2016). Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Clinical &Amp; Experimental Ophthalmology, 44(3), 181-187. https://doi.org/10.1111/ceo.12644
Lamy, Ricardo, Elliot Chan, Samuel D Good, Vicky Cevallos, Travis C Porco, and Jay M Stewart. “Riboflavin and Ultraviolet A As Adjuvant Treatment Against Acanthamoeba Cysts”. Clinical &Amp; Experimental Ophthalmology 44, no. 3 (2016): 181-87. https://doi.org/10.1111/ceo.12644.
Lamy R, Chan E, Good SD, Cevallos V, Porco TC, Stewart JM. Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Clinical & Experimental Ophthalmology. 2016;44(3):181-7.
Journal Categories
Medicine
Medicine (General)
Medicine
Ophthalmology
You May Also Like
- The number of people with glaucoma worldwide in 2010 and 2020
- Global estimates of visual impairment: 2010
- The definition and classification of glaucoma in prevalence surveys
- Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis
- Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates | 1995 | |||
| Growth of Acanthamoeba on human corneal epithelial cells and keratocytes in vitro | 1991 | |||
| Acanthamoeba: Biology and Pathogenesis | 2009 | |||
| Acanthamoeba Keratitis: Diagnosis and Treatment Update 2009 | American Journal of Ophthalmology |
| 311 | 2009 |
| Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America | Eye |
| 216 | 2002 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Corneal changes after fulguration and cross-linking in experiment | Ophthalmology Reports | 2024 | ||
Collagen cross-linking beyond corneal ectasia: A comprehensive review | Indian Journal of Ophthalmology |
| 2024 | |
| Use of corneal cross-linking beyond keratoconus: a systemic literature review | Graefe's Archive for Clinical and Experimental Ophthalmology |
| 3 | 2023 |
| In vitro antimicrobial efficacy of riboflavin, ultraviolet-A radiation, and combined riboflavin/ultraviolet-A radiation on ocular pathogens | Taiwan Journal of Ophthalmology |
| 2023 | |
| Treatment of recalcitrant Acanthamoeba Keratitis with Photoactivated Chromophore for Infectious Keratitis Corneal Collagen Cross-Linking (PACK-CXL) | American Journal of Ophthalmology Case Reports | 9 | 2022 |
Citations Analysis
The category
Medicine: Ophthalmology 7
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled In-vitro development of an effective treatment for Acanthamoeba keratitis and was published in 2017. The most recent citation comes from a 2024 study titled Collagen cross-linking beyond corneal ectasia: A comprehensive review. This article reached its peak citation in 2021, with 3 citations. It has been cited in 13 different journals, 38% of which are open access. Among related journals, the American Journal of Ophthalmology Case Reports cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.